UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 22, 2020

 

THEMAVEN, INC.

(Exact Name of Registrant as Specified in Charter)

 

DELAWARE   1-12471   68-0232575

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1500 Fourth Avenue, Suite 200 Seattle, WA   98101
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 775-600-2765

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name on exchange on which registered
None   -   -

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction .2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

* Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Act of 1934 (§240.12b-2 of this chapter)

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 
 

 

Item 1.01 Entry into Material Definitive Agreement.

 

Series K Securities Purchase Agreement

 

TheMaven, Inc., ( “Maven”) entered into securities purchase agreements (the “Securities Purchase Agreements”) on October 23, 2020 and October 28, 2020, in a single private placement of its securities with several accredited investors (the “Investors”). In the offering Maven sold an aggregate of 12,042 shares of Series K Convertible Preferred Stock, par value $0.01 per share (the “Series K Preferred Stock”), at a per share stated value of $1,000 (the “Stated Value”). The Series K Preferred Stock is initially convertible into 30,105,225 shares of Maven’s common stock, par value $0.01 per share (the “Common Stock”), at a conversion rate equal to the Stated Value divided by the conversion price of $0.40. The aggregate gross proceeds was $12.0 million.

 

Of the gross proceeds received in the offering, approximately $8.6 million were cash proceeds from several investors, which will be used for general corporate purposes and payment on a prior investment of $2.6 million, and approximately $3.4 million represented conversion of outstanding amounts under the existing debt facility between Maven and BRF Finance Co., LLC.

 

The number of shares issuable upon conversion of the Series K Preferred Stock will be adjusted in the event of stock splits, stock dividends, combinations of shares and similar transactions. All of the shares of Series K Preferred Stock convert automatically into shares of Common Stock on the date an amendment to Maven’s Certificate of Incorporation is filed and accepted with the State of Delaware that increases the number of authorized shares of Common Stock to at least a number permitting all the Series K Preferred Stock, and all of Maven’s Series J Convertible Preferred Stock, Series I Convertible Preferred Stock and Series H Convertible Preferred Stock, to be converted in full. Officers of Maven have the right to vote the issued shares of Series K Preferred Stock in favor of the foregoing certificate of incorporation amendments to increase the authorized share capitalization of the company and any reverse stock split proposed by the board of directors.

 

B. Riley FBR, Inc., a full service investment bank and wholly-owned subsidiary of B. Riley Financial, Inc. (“B. Riley”) acted as placement agent for the financing and earned a fee of $520,500 in consideration for its services.

 

Additionally, pursuant to a Registration Rights Agreement (“Registration Rights Agreement”) entered into in connection with the Securities Purchase Agreements, Maven agreed to register the shares issuable upon conversion of the Series K Preferred Stock for resale by the Investors. Maven has committed to file the registration statement by no later than the 30th calendar day following the date the Company files its (a) Annual Reports on Form 10-K for the fiscal year ended December 31, 2018 and December 31, 2019, (b) all its required Quarterly Reports on Form 10-Q since the quarter ended September 30, 2018, through the quarter ended September 30, 2020, and (c) any Form 8-K Reports that the Company is required to file with the Commission; provided, however, if such 30th calendar day is on or after February 12, 2021, then such 30th calendar date shall be tolled until the 30th calendar day following the date that the Company files its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Filing Date”). Maven has also committed to cause the registration statement to become effective by no later than 90 days after the Filing Date (or, in the event of a full review by the staff of the Securities and Exchange Commission, 120 days following the Filing Date). The Registration Rights Agreement provides for liquidated damages upon the occurrence of certain events up to a maximum amount of 6% of the aggregate amount invested by such Investor pursuant to the Securities Purchase Agreement.

 

Amendment to Second Amended and Restated Note Purchase Agreement

 

On October 23, 2020, the Company entered into Amendment No. 1 to Second Amended and Restated Note Purchase Agreement (the “Amended Note Purchase Agreement”) with the guarantors from time to time party thereto, each of the purchasers from time to time named on Schedule I attached thereto and BRF Finance Co., LLC, in its capacity as agent for the purchasers. The material terms of the Amended Note Purchase Agreement are as follows:

 

  The September 30, 2020, interest payment to be paid in the form of PIK Interest;
 

 
  The December 31, 2020, interest payment and all interest payments due in 2021, are to be paid in the form of PIK Interest or, at the option of each note holder, to have all or a portion of the amount of interest then due paid in the form of the Company’s Series K Preferred Stock or, in the event that the Series K Preferred Stock has been converted into shares of the Company’s common stock, in common stock;

 

 
 

 

  The maturity date of the principal amount of the delayed draw term notes due on March 31, 2021 (the “Delayed Draw First Maturity Notes”) is changed to March 31, 2022;
     
  The maturity date of the notes (other than the Delayed Draw First Maturity Notes) is changed from June 14, 2022 to December 31, 2022;
     
  Each holder of notes is provided with the option to convert up to the Conversion Portion (as defined below) of the Delayed Draw First Maturity Notes into Series K Preferred Stock (or common stock if the Series K Preferred Stock has been converted into common stock at such time). “Conversion Portion” means 28% of the aggregate cash proceeds received by the Company from the issuance and sale of Series K Preferred Stock during the 90-day period commencing October 23, 2020 (the “Series K Exception Period”);
     
  The requirement to make mandatory prepayments on the notes out of proceeds received from sales of the Company’s equity, including the proceeds received from the issuance and sale of the Series K Preferred Stock during the Series K Exception Period, is waived; and
     
  In connection with a note holder’s election to receive Series K Preferred Stock (or shares of common stock upon the conversion in such shares of the Series K Preferred Stock), the aggregate liquidation preference of the Series K Preferred Stock to be issued for each $1,000 of obligations under the notes so converted, will be based on the purchase price paid for $1,000 in liquidation preference of the Series K Preferred Stock during the Series K Exception Period.

 

The foregoing is only a brief description of the respective material terms of the Securities Purchase Agreements, the Registration Rights Agreement and the Amended Note Purchase Agreement and is qualified in its entirety by reference to the form of Securities Purchase Agreements, the form of Registration Rights Agreement and Amended Note Purchase Agreement that are filed as Exhibits 10.1, 10.2 and 10.3, respectively, to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 3.02 — Unregistered Sales of Equity Securities

 

The information required by this item is incorporated by reference from Item 1.01 hereof.

 

The securities sold in this financing have not been registered under the Securities Act of 1933, as amended (the “Act”), pursuant to an exemption under Section 4(a)(2) of the Act and Regulation D promulgated thereunder for transactions of an issuer not involving a public offering, and may not be offered or sold in the United States absent registration under the Act or an exemption from such registration requirements.

 

 
 

 

Item 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

 

On October 22, 2020, Maven filed a Certificate of Designation of Preferences, Rights and Limitations of Series K Convertible Preferred Stock (the “Series K Certificate of Designation”) with the Secretary of State of the State of Delaware, pursuant to which Maven designated 20,000 shares of Preferred Stock, par value $0.01 per share, as Series K Convertible Preferred Stock (“Series K Preferred Stock”). Shares of Series K Preferred Stock shall vote with the shares of Common Stock on an as-converted basis, have certain customer protective provisions and are only entitled to dividends if and to the extent any dividends are paid on the shares of Maven’s Common Stock. Additional information required by this item is incorporated by reference from Item 1.01 hereof.

 

The foregoing is only a brief description of the Series K Certificate of Designation and is qualified in its entirety by reference to the Series K Certificate of Designation that is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01 — Financial Statements and Exhibits.

 

(d) Exhibits

 

 

  Exhibit No.   Description
       
  3.1   Certificate of Designation of Preferences, Rights and Limitations of Series K Convertible Preferred Stock, filed October 22, 2020
       
  10.1   Form of Securities Purchase Agreement among TheMaven, Inc. and each of the several purchasers signatory thereto
       
  10.2   Form of Registration Rights Agreement among TheMaven, Inc. and each of the several purchasers signatory thereto
       
  10.3   Amendment No. 1 to Second Amended and Restated Note Purchase Agreement among TheMaven, Inc., the guarantors from time to time party thereto, each of the purchasers from time to time named on Schedule I attached thereto and BRF Finance Co., LLC, in its capacity as agent for the purchasers.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  THEMAVEN, INC.
     
Dated: October 28, 2020 By: /s/ Doug Smith
  Name: Doug Smith
  Title: Chief Financial Officer